返回

癌症, 推廣, 學術
[HOY TV Health Focus] Codex was recently invited to introduce our liquid biopsy test for detecting early-stage breast cancer recurrence on the HOY TV Health Focus TV show | Guardant Reveal | Cancer Liquid Biopsy
Codex recently featured on a TV show to introduce our groundbreaking liquid biopsy test for early-stage cancer recurrence detection. This innovative test represents a significant advancement in cancer diagnostics, offering a non-invasive and highly accurate method to detect cancer recurrence at its earliest stages.
Watch the full interview here: HOY TV Show Health Focus - Episode 227
Guardant Reveal is the first completely tissue-free minimal residual disease (MRD) test, capable of accurately detecting cancer recurrence at an early stage by analyzing circulating tumor DNA (ctDNA) in the blood.
A heartfelt thank you to our dedicated team and everyone who has supported us. Let’s move towards a healthier future together. 💪✨
#CancerDetection #LiquidBiopsy #Innovation #Healthcare #EarlyDetection #CancerResearch